Results 131 to 140 of about 396,801 (209)

Toll-Like Receptor Signaling in Liver Diseases

Gastroenterology Research and Practice, 2010
Gyongyi Szabo, Timothy R. Billiar, Keigo Machida, Ian Nicholas Crispe, Ekihiro Seki   +4 more
doaj   +1 more source

Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target. [PDF]

Front Immunol
Crammond P, Hastak P, Delaney A, Sasson SC.   +3 more
europepmc   +1 more source

The role of soluble toll-like receptor-2 and 4 in children with pneumonia: a combined analysis of saliva and serum samples. [PDF]

Front Immunol
Necipoglu O, Demir OO, Aykac K, Karahan S, Cengiz AB, Aydin M, Ozsurekci Y.   +6 more
europepmc   +1 more source

The association between toll-like receptor gene polymorphism and Helicobacter pylori infection risk: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Xu Z, Sun X, Dong Q, Xu Z, Li Z, Wang L.
europepmc   +1 more source

Expression of Concern: Toll-Like Receptor 2 Targeted Rectification of Impaired CD8+ T Cell Functions in Experimental Leishmania donovani Infection Reinstates Host Protection. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Targeting Toll-like Receptor 2: synthetic diacylated lipopeptides polarize equine macrophages towards a pro-inflammatory phenotype. [PDF]

Front Immunol
De Ciucis CG, Fruscione F, Dell'Anno F, Zinellu S, Giaconi E, Loi S, Columbano N, Franzoni G, Razzuoli E.   +8 more
europepmc   +1 more source

Fut8-Mediated Core Fucosylation of Toll-Like Receptor 4 Exacerbates Periodontitis Via Hyperactivation of NF-κB Signalling. [PDF]

Int Dent J
Lin J, Luo Y, Chen L, Zeng C, Wang L, Luo X, Zeng L, Xu H, Chen Z.   +8 more
europepmc   +1 more source

Circulating Toll-like receptor and cytokine profiles and genetic polymorphisms in a Chinese sepsis cohort: potential links to neuroinflammation and blood-brain barrier dysfunction. [PDF]

Front Immunol
Fan W, Zhao R, Liu J, Luo R, Chen Y.
europepmc   +1 more source

Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives. [PDF]

J Med Chem
Lami F, Romerio A, Valle-Gómez L, Martín-Cámara O, Martín-Santamaría S, Peri F.   +5 more
europepmc   +1 more source

Diverse Effects of Various Toll-Like Receptor 2 Ligands on Neuronal Activity and Cell Death. [PDF]

Cell Mol Neurobiol
Sato F, Hachimura S.
europepmc   +1 more source